Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection.

  • Read more about Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection.

The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine

  • Read more about The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine

Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs

  • Read more about Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs

Consequences of COVID-19 Infection for Child Health and Wellbeing: Protocol for a Prospective, Observational, Longitudinal Study in Children

  • Read more about Consequences of COVID-19 Infection for Child Health and Wellbeing: Protocol for a Prospective, Observational, Longitudinal Study in Children

Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose

  • Read more about Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose

Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19

  • Read more about Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19

Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

  • Read more about Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19

  • Read more about Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19

PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway

  • Read more about PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway

Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome

  • Read more about Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 115
  • Page 116
  • Page 117
  • Page 118
  • Current page 119
  • Page 120
  • Page 121
  • Page 122
  • Page 123
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA